Literature DB >> 16157450

Association studies of cholesterol metabolism genes (CH25H, ABCA1 and CH24H) in Alzheimer's disease.

Nobuto Shibata1, Toshitaka Kawarai, Joseph H Lee, Hye-Seung Lee, Eri Shibata, Christine Sato, Yan Liang, Rajan Duara, Richard P Mayeux, Peter H St George-Hyslop, Ekaterina Rogaeva.   

Abstract

Recent studies have demonstrated that cholesterol metabolism has an important role in Alzheimer's disease (AD) pathogenesis, suggesting that cholesterol-related genes may be significant genetic risk factors for AD. Based on the results of genome-wide screens, along with biological studies, we selected three genes as candidates for AD risk factors: ATP-binding cassette transporter A1 (ABCA1), cholesterol 25-hydroxylase (CH25H) and cholesterol 24-hydroxylase (CH24H). Case-control of North American Caucasians and AD families of Caribbean Hispanic origin were examined. Although excellent biological candidates, the case-control dataset did not support the hypothesis that these three genes were associated with susceptibility to AD. Similarly, no association was found in the Caribbean Hispanic families for CH25H. However, we did observe a possible interaction between ABCA1 and APOE in the Hispanics.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16157450     DOI: 10.1016/j.neulet.2005.08.048

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  28 in total

Review 1.  Dyslipidemia and dementia: current epidemiology, genetic evidence, and mechanisms behind the associations.

Authors:  Christiane Reitz
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

Review 2.  The role of ATP-binding cassette transporter A1 in Alzheimer's disease and neurodegeneration.

Authors:  Radosveta Koldamova; Nicholas F Fitz; Iliya Lefterov
Journal:  Biochim Biophys Acta       Date:  2010-02-24

3.  Abca1 deficiency affects Alzheimer's disease-like phenotype in human ApoE4 but not in ApoE3-targeted replacement mice.

Authors:  Nicholas F Fitz; Andrea A Cronican; Muzamil Saleem; Abdul H Fauq; Robert Chapman; Iliya Lefterov; Radosveta Koldamova
Journal:  J Neurosci       Date:  2012-09-19       Impact factor: 6.167

Review 4.  ATP-binding cassette transporter A1: from metabolism to neurodegeneration.

Authors:  Radosveta Koldamova; Nicholas F Fitz; Iliya Lefterov
Journal:  Neurobiol Dis       Date:  2014-05-17       Impact factor: 5.996

5.  A Generic Sure Independence Screening Procedure.

Authors:  Wenliang Pan; Xueqin Wang; Weinan Xiao; Hongtu Zhu
Journal:  J Am Stat Assoc       Date:  2018-08-06       Impact factor: 5.033

6.  A survey of ABCA1 sequence variation confirms association with dementia.

Authors:  Chandra A Reynolds; Mun-Gwan Hong; Ulrika K Eriksson; Kaj Blennow; Anna M Bennet; Boo Johansson; Bo Malmberg; Stig Berg; Fredrik Wiklund; Margaret Gatz; Nancy L Pedersen; Jonathan A Prince
Journal:  Hum Mutat       Date:  2009-09       Impact factor: 4.878

Review 7.  CYP46A1 T/C polymorphism associated with the APOE ε4 allele increases the risk of Alzheimer's disease.

Authors:  Ling Li; Zegang Yin; Juan Liu; Gongbo Li; Yanjiang Wang; Jiachuan Yan; Huadong Zhou
Journal:  J Neurol       Date:  2012-10-16       Impact factor: 4.849

Review 8.  Role of cholesterol in APP metabolism and its significance in Alzheimer's disease pathogenesis.

Authors:  M Maulik; D Westaway; J H Jhamandas; S Kar
Journal:  Mol Neurobiol       Date:  2012-09-16       Impact factor: 5.590

Review 9.  Cholesterol 24-hydroxylase: an enzyme of cholesterol turnover in the brain.

Authors:  David W Russell; Rebekkah W Halford; Denise M O Ramirez; Rahul Shah; Tiina Kotti
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

10.  Association between selected cholesterol-related gene polymorphisms and Alzheimer's disease in a Turkish cohort.

Authors:  Gamze Guven; Eren Vurgun; Basar Bilgic; Hasmet Hanagasi; Hakan Gurvit; Ebru Ozer; Ebba Lohmann; Nihan Erginel-Unaltuna
Journal:  Mol Biol Rep       Date:  2019-01-25       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.